The management of intraductal papillary mucinous neoplasm (IPMN) continues to evolve. In
particular, the indications for resection of branch duct IPMN have changed from early …

The international consensus guidelines for management of intraductal papillary mucinous
neoplasm and mucinous cystic neoplasm of the pancreas established in 2006 have …

Pancreatic cystic lesions (PCLs) are being increasingly identified in recent years. They show
a wide spectrum of imaging and clinical features. The diagnosis and discrimination of these …

Approximately 10% of persons 70 years old or older are now diagnosed with pancreatic
cysts, but it is not clear which ones require additional analysis, interventions, or follow-up …

Cystic neoplasms of the pancreas are found with increasing prevalence, especially in
elderly asymptomatic individuals. Although the overall risk of malignancy is very low, the …

OBJECTIVE. The purpose of this review is to outline the management guidelines for the care
of patients with cystic pancreatic lesions. CONCLUSION. The guidelines are as follows …

Objective: Evaluate the value of cytology relative to imaging features in risk assessment for
malignancy as defined in the Sendai Guidelines. Background: The Sendai Guidelines list …

OBJECTIVES: To investigate environmental, personal, and hereditary risk factors associated
with the occurrence of intraductal papillary mucinous neoplasms of the pancreas (IPMNs) …

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal malignancies, which is
usually diagnosed at an advanced stage. The late disease diagnosis, the limited availability …

BACKGROUND: The Sendai guidelines for risk assessment of malignancy in patients with
mucinous cysts lists “positive” cytology as a high‐risk feature. In the current study, the …